OT: Stock trading | Page 68 | The Boneyard

OT: Stock trading

UConnSwag11 said:
Gold Telegraph tweet: The Treasury Department has published guidance clarifying an executive order U.S investors can NO LONGER invest in ETFs and index funds as well as subsidiaries of Chinese companies designated as owned or controlled by the Chinese military
Expand ...

Comic gold:

Apparently, Gold Telegraph, the original tweeter did not understand the initial November US Treasury executive order, is massively ill informed regarding today's related guidance, and is unaware western investment managers, pension administrators, and global indices including MSCI, S&P DJ, and FTSE Russell have already been acting to purge mainland companies the Office of Foreign Assets Control identified as being owned or >50% controlled by the mainland PLA. ;)

However, it would be entertaining to learn which ETFs, index funds, etc managed by US-domiciled or other western managers or indices used by US companies or marketed in the US the clueless Gold Telegraph tweeter believes the PLA owns or controls? /s
 
Da_Aisijimo_Gou said:
Comic gold:

Apparently, Gold Telegraph, the original tweeter did not understand the initial November US Treasury executive order, is massively ill informed regarding today's related guidance, and is unaware western investment managers, pension administrators, and global indices including MSCI, S&P DJ, and FTSE Russell have already been acting to purge mainland companies the Office of Foreign Assets Control identified as being owned or >50% controlled by the mainland PLA. ;)

However, it would be entertaining to learn which ETFs, index funds, etc managed by US-domiciled or other western managers or indices used by US companies or marketed in the US the clueless Gold Telegraph tweeter believes the PLA owns or controls? /s
Expand ...
www.state.gov

U.S. Investors Are Funding Malign PRC Companies on Major Indices - United States Department of State

Under Xi Jinping, the CCP has prioritized something called ‘military-civil fusion.’ … Chinese companies and researchers must… under penalty of law – share technology with the Chinese military. The goal is to ensure that the People’s Liberation Army has military dominance.  And the PLA’s core...
www.state.gov www.state.gov
 
UConnSwag11 said:
www.state.gov

U.S. Investors Are Funding Malign PRC Companies on Major Indices - United States Department of State

Under Xi Jinping, the CCP has prioritized something called ‘military-civil fusion.’ … Chinese companies and researchers must… under penalty of law – share technology with the Chinese military. The goal is to ensure that the People’s Liberation Army has military dominance.  And the PLA’s core...
www.state.gov www.state.gov
Expand ...
Analyze the actual facts. Today's Treasury guidance is neither really new nor did the Gold Telegraph tweeter understand the actual facts. Simply, explanatory information after the Treasury acted in November in response to Central Government actions your link references.

Today's guidance simply further clarified prior documented facts well communicated by State. Investment managers and indices are well informed of the prior November facts and had already begun purging mainland companies owned or >50% owned by the Central Government and/or its' PLA, e.g., SMIC. The funniest part is the Gold Telegraph tweeter inexplicably suggested the Central Government owns or controls US or other western fund managers and indices. Rich!
 
Zionn said:
$ IPOC is ready for take off .......
Expand ...
I bought it today right before close. Plan to sell it Jan 6th right before the merger vote. If merger is approved, the Clover stock goes live Jan 8th.
 
FYI if anyone has been buying SPACs, check if the SPAC is registered to a location in the USA. If it’s located in the Cayman Islands, it can create unfavorable tax issues holding it into the new year. Look up PFIC for more info on the tax implications.

You can see where the SPAC is registered on this site.

IPOC Stock - Clover Health Investments, Corp. /de SEC Filings

Security and Exchange Commission filings for CLOVER HEALTH INVESTMENTS, CORP. /DE (IPOC)
sec.report sec.report
 
Last edited:
Should’ve asked this yesterday: what were the best picks, worst picks, and picks that will be great in 2021? Stocks, ETFs, mutual funds, etc
 
Da_Aisijimo_Gou said:
With similar objectives, holdings, risk, volatility, and close returns, why buy the high front-end loaded ADNPX with markedly-higher annual fees and a shorter track record (2017) vs ARKK (est 2014) with no front-end and just 45% of ADNPX's annual fees?
Expand ...

It does have a high expense ratio - that is the one thing I wrestled with. I have found that I'll hold onto a good mutual fund longer vs trading in and out of ETF's, which I have a tendency (weakness perhaps) to do. As far as front end ADNPX expenses, to my research, I could not find anything:

American Beacon ARK Trans Innov Inv (ADNPX) MUTUAL FUND RESEARCH

Should you invest in American Beacon ARK Trans Innov Inv ADNPX? MAXfunds.com provides easy-to-understand data on American Beacon ARK Trans Innov Inv ADNPX and more than 22,000 other mutual funds. Find out American Beacon ARK Trans Innov Inv's MAXrating - the one number you need to know before...
www.maxfunds.com
 
My main crypto buys are going to be $DOT, $ETH, $LINK, $KIN, $OCEAN, $FLARE, (when they're released), and $XRP (still). Those are my main buys as of now.
 
Road2Five said:
what are the projections for CYDY? Any idea? It’s 5.39 right now. Also what do you use to purchase?
Expand ...


First of all, I am a swing trader, not an investor. Looking at the charts, CYDY is showing a very bullish pattern and If I were to project out 6-8 weeks, with positive news the stock "could" go to the 10-15 range.
All of the indicators/oscillators MACD, MOM, SMA are all indicating "buy" . Near term, next 5 days my price target is 6.50-6.75 in which case I would take profit and re-enter a new trade if it retests support of 5.60-5.75 range. I use both Lightspeed and Fidelity Pro for equities and Forex trading.

On another note, I am reading that CYDY's therapeutic may be more effective then remdesivir, phase 3 anaylsis and FDA guidance is expected in the next 4-6 weeks??
 
Happy New Year guys. Rough last week for me but still a blessed year overall. Sold a lot of stuff Thursday to eliminate margin and be well positioned with cash for any sizable pullbacks. I’m going to try to trade a little more this year, focused right now on Micron (MU) before earnings on Thursday.
 
Scud49 said:
It does have a high expense ratio - that is the one thing I wrestled with. I have found that I'll hold onto a good mutual fund longer vs trading in and out of ETF's, which I have a tendency (weakness perhaps) to do. As far as front end ADNPX expenses, to my research, I could not find anything:
Expand ...
No doubt ADNPX's high fees (1.34%) are cost prohibitive for many people vs ARKK (0.75%), but neither are typically considered quick trading, flipping vehicles. Thanks for the current correction regarding ADNPX's front load. Perhaps for fear of losing sales to the financially sounder ARKK, American Beacon killed their original load. Good luck with the mutual fund.
 
The regulators are going after foreign exchanges. They're also going after privacy and stablecoins
 
Last edited:
Road2Five said:
what are the projections for CYDY? Any idea? It’s 5.39 right now. Also what do you use to purchase?
Expand ...
Late Mar-early Apr, bought some of the typically very lightly traded CYDY <3 in a Roth solely used for riskier chances. Then and now, I never believed CYDY's particularly well managed, it remains in the grays and hence has virtually no institutional holders (ahead of possible move to Nasdaq). That said, CYDY's recently added more-competent pharma leaders, begun to enhance their financials, signed prospective manufacturing agreements with Samsung Biologics and Ajinomoto (FDA-clearance dependent), and CYDY's Leronlimab/Vyrologix may luck into a narrowly-scoped FDA clearance for severe-to-critical SARS-2 patients (potentially later, other uses for Covid-19 long haulers and for breast cancer, HIV, NASH, etc.).

CYDY's been up and down like a trampolined-kid since March. Not being much of a trader, I intended to hold the initial shares for a year, win or lose. Then, sold enough shares to break even >6 up to >9, and added more <3 as recent as Nov. Jader's likely correct, CYDY will potentially bump up Monday, shorters will try to pound it back down as they have since March, and CYDY may rise up again up to a Wednesday conference call into Thursday, repeat ...

Sometime later in January, the Leronlimab/Vyrologix Phase III trial results for severe-to-critical patients will be unblinded. Forget about investments, ideally the FDA grants EUA such that an actual effective, therapeutic treatment finally exists. Knocking on wood for our country.
 
Da_Aisijimo_Gou said:
No doubt ADNPX's high fees (1.34%) are cost prohibitive for many people vs ARKK (0.75%), but neither are typically considered quick trading, flipping vehicles. Thanks for the current correction regarding ADNPX's front load. Perhaps for fear of losing sales to the financially sounder ARKK, American Beacon killed their original load. Good luck with the mutual fund.
Expand ...
Thanks on the fund, we shall see what the new year brings. I did buy both ARKG and ARKK this past Wednesday on their respective dips. Cathie is incredibly bullish on the genomics sector for 2021 and beyond- thus far I appreciate her and her team's boldness and vision, she has my confidence.
 
You must log in or register to reply here.

Online statistics

Members online
236
Guests online
1,553
Total visitors
1,789
Totals may include hidden visitors.

Share This Page

Forum statistics

Threads
164,008
Messages
4,378,440
Members
10,170
Latest member
ctfb19382


.
..
Top Bottom